Official UK visa sponsor profile for Alchemab Therapeutics Limited in Cambridge, including current register status, route details, and public company data.
Alchemab Therapeutics Limited, registered in England and Wales with registration number 12156844, is an active limited company established on August 14, 2019. The company’s address is East Side Office 1.02, Kings Cross, London, N1C 4AX. It operates within the biotechnology sector, specifically engaging in research and experimental development. Based on information from its website, Alchemab Therapeutics Limited’s company size is currently undefined, with no specific data available regarding its size or services. The company’s key focus is on cell biology game development. There is no evidence of international presence or hiring activity. The company’s operational status is active. Financial records indicate accounts were prepared for the period ending December 31, 2024, with no charges recorded and the company is not insolvent. The company holds a Skilled Worker Visa and a Worker (A rating). Alchemab Therapeutics Limited is a limited company (Ltd). The company’s website describes a game centered around cellular competition, where players control cells to grow and consume others. The game mechanics involve splitting, shrinking, and dodging, utilizing special skins and usernames to gain an advantage.
Official UK visa sponsor profile for Alchemab Therapeutics Limited in Cambridge, including current register status, route details, and public company data.
Alchemab Therapeutics Limited, registered in England and Wales with registration number 12156844, is an active limited company established on August 14, 2019. The company’s address is East Side Office 1.02, Kings Cross, London, N1C 4AX. It operates within the biotechnology sector, specifically engaging in research and experimental development. Based on information from its website, Alchemab Therapeutics Limited’s company size is currently undefined, with no specific data available regarding its size or services. The company’s key focus is on cell biology game development. There is no evidence of international presence or hiring activity. The company’s operational status is active. Financial records indicate accounts were prepared for the period ending December 31, 2024, with no charges recorded and the company is not insolvent. The company holds a Skilled Worker Visa and a Worker (A rating). Alchemab Therapeutics Limited is a limited company (Ltd). The company’s website describes a game centered around cellular competition, where players control cells to grow and consume others. The game mechanics involve splitting, shrinking, and dodging, utilizing special skins and usernames to gain an advantage.
Yes, Alchemab Therapeutics Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Alchemab Therapeutics Limited is classified under: Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Alchemab Therapeutics Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Alchemab Therapeutics Limited is classified under: Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.